
6.01 Delayed Data As of 3:58pm ET | ![]() Today’s Change | 3.43 Today|||52-Week Range 8.22 | -4.75% Year-to-Date |
The 4 analysts offering 12-month price forecasts for Catalyst Biosciences Inc have a median target of 18.00, with a high estimate of 25.00 and a low estimate of 15.00. The median estimate represents a +199.50% increase from the last price of 6.01.
The current consensus among 4 polled investment analysts is to Buy stock in Catalyst Biosciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.